Carbamazepine
- Product NDC
- 67046-1559
- 11-digit product format
- 670461559
- Labeler code
- 67046
- Product ID
- 67046-1559_33ed8bf0-1746-e708-e063-6394a90abde9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- carbamazepine
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Coupler LLC
- Application
- ANDA076697
- Marketing category
- ANDA
- Marketing start
- 2025-04-29
- Substance
- CARBAMAZEPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Carbamazepine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CARBAMAZEPINE | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 33CM23913M |
| Rxcui | 200133 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67046-1559-3 | Carbamazepine | 30 in 1 BLISTER PACK | CAPSULE, EXTENDED RELEASE | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67046-1559 | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [COUPLER LLC] | 1 | Current NDC, 1 package rows | 20250503_33edb22f-f357-ec0f-e063-6394a90a7bc3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 67046-1559-3 | 67046155903 | 30 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (67046-1559-3) | 2025-04-29 | No | No | Current |